Because chemotherapeutic drugs can also act as stressors, it is reasonable to hypothesize that NIBAN might also exert cytoprotective/anti-apoptosis functions in response to GEM treatment in bladder cancer. This evidence concerns the gene NIBAN1 and urinary bladder carcinoma.